Browsing Centre for Biochemical Pharmacology by Subject "HFpEF"

Now showing items 1-2 of 2

    • Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis. 

      Chen, J; Norling, LV; Mesa, JG; Silva, MDP; Burton, SE; Reutelingsperger, C; Perretti, M; Cooper, D (National Academy of Sciences, 2021-09-21)
      Rheumatoid arthritis (RA) carries a twofold increased incidence of heart failure with preserved ejection fraction, accompanied by diastolic dysfunction, which can lead to death. The causes of diastolic dysfunction are ...

    • Immunometabolic Mechanisms of Heart Failure with Preserved Ejection Fraction. 

      Schiattarella, GG; Alcaide, P; Condorelli, G; Gillette, TG; Heymans, S; Jones, EAV; Kallikourdis, M; Lichtman, A; Marelli-Berg, F; Shah, S (2022-03)
      Heart failure with preserved ejection fraction (HFpEF) is increasing in prevalence worldwide, already accounting for at least half of all heart failure (HF). As most patients with HFpEF are obese with metabolic syndrome, ...